OBI — Ondine Biomedical Share News
0.000.00%
Last trade - 00:00- £41.00m
- £40.53m
- CA$1.20m
REG - Ondine Biomedical - Corporate and Trading Update
AnnouncementRCS - Ondine Biomedical - Steriwave in first Australian hospital
AnnouncementRCS - Ondine Biomedical - 32% Fewer SSIs After Steriwave Replaced Mupirocin
AnnouncementRCS - Ondine Biomedical - Steriwave authorized for use by HCA UK
AnnouncementRCS - Ondine Biomedical - Entry into ICU market expands revenue potential
AnnouncementREG - Ondine Biomedical - Appointment of Interim Chief Financial Officer
AnnouncementREG - Ondine Biomedical - First commercial adoption of Steriwave by the NHS
AnnouncementRCS - Ondine Biomedical - Steriwave study shows 77% drop in antibiotic use
AnnouncementRCS - Ondine Biomedical - Steriwave deploying in eight new sites
AnnouncementRCS - Ondine Biomedical - Ondine starts first UK health economics study
AnnouncementRCS - Ondine Biomedical - Microbiome research supports use of Steriwave
AnnouncementREG - Ondine Biomedical - Grant of Share Options
AnnouncementRCS - Ondine Biomedical - Ondine unveils new research at SPIE Photonics West
AnnouncementREG - Ondine Biomedical - Appointment of new Chief Financial Officer
AnnouncementREG - AIM - AIM Notice - 15/12/2023
AnnouncementRCS - Ondine Biomedical - C$4.91 raise supports ongoing commercialisation
AnnouncementREG - Ondine Biomedical - TR-1: NOTIFICATION OF MAJOR HOLDINGS
AnnouncementREG - Ondine Biomedical - Result of Fundraising
AnnouncementREG - AIM - AIM Notice - 08/12/2023
Announcement